See more : TAYA Co.,Ltd. (4679.T) Income Statement Analysis – Financial Results
Complete financial analysis of SS Innovations International, Inc. (SSII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SS Innovations International, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Sopra Steria Group SA (SPSAF) Income Statement Analysis – Financial Results
- Netmarble Corporation (251270.KS) Income Statement Analysis – Financial Results
- DEUTSCHE BANK AG LONDON (WMWXF) Income Statement Analysis – Financial Results
- Royal Unibrew A/S (ROYUF) Income Statement Analysis – Financial Results
- Skyharbour Resources Ltd. (SYH.V) Income Statement Analysis – Financial Results
SS Innovations International, Inc. (SSII)
About SS Innovations International, Inc.
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.88M | 1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 5.17M | 968.72K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| Gross Profit | 713.45K | 489.59K | -18.79K | -37.43K | -37.70K | -19.46K | -789.00 | 0.00 |
| Gross Profit Ratio | 12.13% | 33.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 576.17K | 83.28K | 1.00K | 3.00K | 60.87K | 27.13K | 71.17K | 138.38K |
| General & Administrative | 20.81M | 6.09M | 1.41M | 1.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | -18.79K | -37.43K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.81M | 6.09M | 1.39M | 1.06M | 3.22M | 913.79K | 938.85K | 324.12K |
| Other Expenses | 0.00 | 279.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.38M | 6.17M | 1.39M | 1.07M | 3.28M | 940.92K | 1.01M | 462.49K |
| Cost & Expenses | 26.55M | 7.14M | 1.41M | 1.10M | 3.32M | 960.38K | 1.01M | 462.49K |
| Interest Income | 129.76K | 239.73K | 118.00 | 6.00 | 0.00 | 58.00 | 84.00 | 31.00 |
| Interest Expense | 523.36K | 162.00K | 0.00 | 1.06K | 0.00 | 0.00 | 27.00K | 22.52K |
| Depreciation & Amortization | 162.62K | 128.90K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| EBITDA | -20.26M | -5.31M | -1.47M | -1.09M | -3.33M | -940.86K | -1.01M | -462.46K |
| EBITDA Ratio | -344.51% | -380.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.67M | -5.68M | -1.41M | -1.10M | -3.32M | -960.38K | -1.01M | -462.49K |
| Operating Income Ratio | -351.52% | -389.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -273.60K | 77.73K | -77.27K | -21.75K | -63.29K | 58.00 | -26.91K | -22.49K |
| Income Before Tax | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Income Before Tax Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 3.00 | -1.00 | -2.00 | -3.00 | 2.00 | 0.00 |
| Net Income | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Net Income Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| EPS Diluted | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| Weighted Avg Shares Out | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
| Weighted Avg Shares Out (Dil) | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
U.S. IPO Weekly Recap: Nano-Caps Debut In Quiet Week
U.S. IPO Weekly Recap: Nano-Caps Debut In Quiet Week
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company's First Multi-Specialty Robotic Surgical Conference
Remote coronary artery suturing performed on animal model via SS Innovations' telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery FORT LAUDERDALE, FL, February 01, 2024 – SS Innovations International, Inc.
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company's First Multi-Specialty Robotic Surgical Conference
Remote coronary artery suturing performed on animal model via SS Innovations' telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery FORT LAUDERDALE, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- SS Innovations International,...
SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration
FORT LAUDERDALE, FL, January 26, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that...
SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration
FORT LAUDERDALE, Fla., Jan. 26, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today...
SS Innovations Partners with India's Leading Medical Equipment Supplier, Medikabazaar
Collaboration to facilitate sales of the SSi Mantra Surgical Robotic System to hospitals and medical facilities across India FORT LAUDERDALE, FL, January 25, 2024 – SS Innovations International, Inc.
SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference
SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System Distinguished guests included the Honorable Governor...
SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference
SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System Distinguished guests included the Honorable Governor...
SS Innovations Achieves Significant Milestones in 2023
Company's award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures Company Builds Strong Foundation for Future Growth FORT LAUDERDALE, FL, January 8, 2024...
SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa
Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries FORT LAUDERDALE, FL, December 26, 2023...
Source: https://incomestatements.info
Category: Stock Reports